Clinical and Dynamic Floor MRI Evaluation Before and After Prolapse Surgery

July 18, 2022 updated by: Tatiana Besse-Hammer

Pre- and Postoperative Dynamic Floor MRI in Order to Evaluate the Anatomical and Functional Changes of the Different Pelvic Floor Organs, Before and After Prolapse Surgery.

Pelvic organ prolapsed, associated with defecation disorders and urinary tracts symptoms are common and affect up to 25% of the population, mostly parous women. The pelvic floor must be seen as one entity, with multiple anatomical and physiological interactions between the various compartments (rectum, vagina, uterus and bladder) which are embedded in the same anatomical region. The often complex pathologies of this region should therefore be treated in a multidisciplinary setting.

Besides clinical evaluation, functional dynamic imaging of anorectal and pelvic floor disfunctions has an important role in the diagnosis and management of these disorders. Although the colpocystodefecography is still considered to be the golden standard in imaging this complex anatomical region, there is clearly a need for more precise imaging of the structural details, preferentially without any irradiation. Transperineal ultrasound is an option but the investigators have chosen to evaluate the use of dynamic magnetic resonance imaging. In contrast to colpocystodefecography, dynamic pelvic floor magnetic resonance imaging is an evolving technology and its precise role in functional imaging of the pelvic floor still remains to be determined.

Prolapse surgery is commonly performed and therefore it is important to assess the efficacy of the operations in correcting the anatomical defects and the symptoms associated without creating new, pelvic floor related symptoms. Few studies exist today allowing the assessment of the anatomical changes and symptoms after surgery, through abdominal or perineal approach.

This study will evaluate the reliability of the dynamic pelvic floor imaging, done in a sitting position, compared to colpocystodefecography, done in a sitting position. It will also compare clinical objective and subjective results related to pelvic floor abnormalities with imaging. Finally, it will evaluate the anatomical changes in correlation with the clinical results, organ position and inter-compartments relationships after surgery.

This study will allow to understand and explain some relapses and failures and could lead to an improvement of the indications for surgery and surgical techniques used.

Study Overview

Study Type

Observational

Enrollment (Actual)

34

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussel, Belgium, 1020
        • CHU Brugmann
      • Brussels, Belgium
        • Chu St Pierre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients who will be operated for symptomatic rectal intussusception or prolapse, enterocele and/or urogenital prolapse, though abdominal and persineal approach as well.

Description

Inclusion Criteria:

All patients who will undergo internal or external rectal prolapse, enterocele or urogenital prolapse surgery in CHU Brugmann and CHU St Pierre.

Exclusion Criteria:

  • MRI contra-indications
  • Patients with prior pelvic floor surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Prolapse surgery
Dynamic floor magnetic resonance imaging (MRI)
Colpocystodefecography (CCD)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
recto-anal angle -relax position
Time Frame: 6 months post surgery
Measured by dynamic floor MRI in left lateral decubitus position (141°)
6 months post surgery
recto-anal angle -retain position
Time Frame: 6 months post surgery
Measured by dynamic floor MRI in left lateral decubitus position (163°)
6 months post surgery
recto-anal angle -push position
Time Frame: 6 months post surgery
Measured by dynamic floor MRI in left lateral decubitus position (165°)
6 months post surgery
recto-anal angle -relax position
Time Frame: 6 months post surgery
Measured by dynamic floor MRI in sitting position (141°)
6 months post surgery
recto-anal angle -retain position
Time Frame: 6 months post surgery
Measured by dynamic floor MRI in sitting position (125°)
6 months post surgery
recto-anal angle -push position
Time Frame: 6 months post surgery
Measured by dynamic floor MRI in sitting position (143°)
6 months post surgery
Dynamic MRI: anterior compartment
Time Frame: 6 months post surgery
From the bladder, discrete inferior descent of the pubococcygeal line: max 1/3 (yes/no)
6 months post surgery
Dynamic MRI: medium compartment
Time Frame: 6 months post surgery
Vagina horizontalization (yes/no)
6 months post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fecal Incontinence Severity Index (FISI)
Time Frame: 6 months post surgery
This is a health tool that describes the severity of different types of incontinence for bowel contents.There are 4 items in the FISI scale with 6 answer choices. Points are awarded according to the gravity of the symptoms. The higher the FISI index (which ranges from 0 to 61), the higher the severity of the fecal incontinence.
6 months post surgery
Constipation scoring system (CCS)
Time Frame: 6 months post surgery
Validated questionnaire. Minimum Score, 0 - Maximum Score, 30
6 months post surgery
Prolapse Quality of Life (P-QOL) questionnaire
Time Frame: 6 months post surgery
Validated questionnaire covering nine domains: general health (1 item), prolapse impact (1 item), role (2 items), physical (2 items) and social limitations (3 items), personal relationships (2 items), emotions (3 items), sleep/energy (2 items), and severity measurement (4 items). The answers are categorized using a fourpoint Likert scale: "none/not at all," "slightly/a little," "moderately," and "a lot." A score is calculated for each domain ranging from 0 to 100. A higher score indicates a greater impairment of quality of life.
6 months post surgery
Sexual function questionnaire (PISQ-IR)
Time Frame: 6 months post surgery
Validated questionnaire. The PISQ-12 measures three domains: behavioral-emotive (items 1 - 4), physical (items 5 - 9) and partner-related (items 10 - 12). It is a self-administered questionnaire, and responses are graded on a five-point Likert scale ranging from 0 (always) to 4 (never). Items 1 - 4 are reversely scored and a total of 48 is the maximum score. Higher scores indicate better sexual function.
6 months post surgery
Visual analogic Scale (VAS)
Time Frame: 6 months post surgery
The VAS scale (EVA in French) is a straight line of 100 mn length. One end is the absence of pain, the other end represents unbearable pain. The patient places a mark between these 2 extremities according to the intensity of his pain at a given time.
6 months post surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katleen Jottard, MD, CHU Brugmann

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2017

Primary Completion (Actual)

October 26, 2021

Study Completion (Actual)

October 26, 2021

Study Registration Dates

First Submitted

January 9, 2018

First Submitted That Met QC Criteria

January 9, 2018

First Posted (Actual)

January 17, 2018

Study Record Updates

Last Update Posted (Actual)

July 19, 2022

Last Update Submitted That Met QC Criteria

July 18, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHUB-prolapse

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prolapse

Clinical Trials on Dynamic floor magnetic resonance imaging

3
Subscribe